Trazodone (Desyrel, Oleptro) and Black patients
Brand names: Desyrel, Oleptro
What Trazodone does
Trazodone was FDA-approved for depression in 1981 but is now prescribed far more often off-label for insomnia at low doses (25–100 mg at bedtime). It is sedating at low doses, has no abuse potential, and is an alternative to benzodiazepines and Z-drugs for chronic insomnia.
What the evidence says for Black patients
Low-dose trazodone for insomnia has weak clinical-trial support across all populations — a 2017 Cochrane review found only small, short-term benefits. But for Black patients specifically, trazodone offers several practical advantages over alternatives:
- Not controlled — avoids the stigma, pharmacy-surveillance burdens, and 'drug-seeking' assumptions that disproportionately affect Black patients seeking pain or sleep medications.
- No documented race-specific efficacy difference.
- Inexpensive and widely available.
- Safer in substance-use-disorder histories than benzodiazepines.
Important Black-patient-specific risk: priapism (prolonged painful erection) is an idiosyncratic but well-documented adverse event with trazodone. Any prolonged erection (over 4 hours) requires emergency care because of ischemic damage. Black men with sickle cell disease are at particularly elevated baseline risk for priapism and should generally avoid trazodone.
Common alternatives
For insomnia: cognitive behavioral therapy for insomnia (CBT-I) as first-line; doxepin low-dose (3–6 mg, FDA-approved for insomnia), melatonin, suvorexant, mirtazapine. Avoid benzodiazepines and Z-drugs for chronic use when possible.
Side effects
- Sedation (usually the desired effect at low doses)
- Orthostatic hypotension
- Dizziness, fall risk in older adults
- Priapism — emergency
- Weight gain (minimal at low doses)
- Serotonin syndrome with MAOIs, triptans
Factors that affect adherence
Take 30 minutes before intended sleep. Rise slowly from bed to avoid orthostatic falls, especially in older adults. Generic is very inexpensive.
Questions to ask your doctor
Bring this list to your next appointment.
- Is CBT-I available as a first-line alternative?
- If I have sickle cell disease, should I avoid trazodone because of priapism risk?
- Can I fall safely if I need to use the bathroom at night?
References
- Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018;45:25–32.
- Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: clinical practice guideline from ACP. Ann Intern Med. 2016;165:125–133.
- U.S. Food and Drug Administration. Desyrel (trazodone) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf
Medical disclaimer
This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.
Read our editorial standards for how we source, review, and update these pages.